Mode
Text Size
Log in / Sign up

Medial Unicompartmental Knee Arthroplasty Shows Small Advantages Over Total Knee Arthroplasty in Severe Anteromedial Knee OsteoarthritisSmaller Knee Surgery Beats Full Replacement on Key Measures

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider mUKA's small advantages over TKA cautiously, as OKS improvement may not meet clinical significance thresholds.

This randomized trial enrolled 350 patients with severe isolated anteromedial knee osteoarthritis across 10 arthroplasty centers to compare medial unicompartmental knee arthroplasty (mUKA) with total knee arthroplasty (TKA) over a 24-month follow-up. The primary outcome was average improvement in the Oxford Knee Score (OKS), with secondary outcomes including Forgotten Joint Score (FJS), range of motion, KOOS symptoms, SF-36 bodily pain, and safety events like reoperations, revision, and death.

Main results showed mUKA had a statistically significant advantage over TKA in OKS improvement, with a difference of 3.5 points (95% CI, 2.3 to 4.7; p < 0.001). Other outcomes favored mUKA: FJS difference of 14.1 points (95% CI, 9.5 to 18.6), range of motion during the first 2 years difference of 7.0 degrees (95% CI, 5.3 to 8.7), range of motion at 2 years difference of 5.5 degrees (95% CI, 3.6 to 7.4), and KOOS symptoms difference of 10.3 points (95% CI, 7.8 to 12.8). SF-36 bodily pain score difference was 7.6 points (95% CI, 4.1 to 11.1). Non-revision reoperations occurred in 4 patients (2.3%) after mUKA versus 12 patients (6.9%) after TKA (95% CI, 0.2% to 9.8%), while revision or death showed no differences.

Safety analysis indicated non-revision reoperations, revision, and death were considered serious adverse events, with discontinuations and tolerability not reported. A key limitation is that the OKS difference of 3.5 points was below the generally accepted minimal clinically important difference of 4 to 5 points, which may limit clinical significance. Practice relevance suggests mUKA and TKA yield similarly favorable short-term results, with small advantages for mUKA, but the evidence does not support clear clinical superiority due to the minor OKS difference.

Two surgeries, one very different experience

The standard choice has long been total knee arthroplasty (TKA) — removing and replacing the entire knee joint with a metal and plastic implant. It works well for most people. But surgeons have long debated whether a smaller operation — medial unicompartmental knee arthroplasty (mUKA), which replaces only the inner worn portion — might be better for patients whose arthritis is limited to one area.

For decades, the answer was unclear. Some surgeons preferred TKA because it felt more "complete." Others argued that removing healthy bone and tissue unnecessarily was the wrong call.

But here's the twist: a major new trial suggests the more targeted approach may actually produce better short-term results in the right patients.

What makes one surgery different

Think of your knee like a house with three rooms. Total knee replacement tears down the whole structure and rebuilds it from scratch. Partial replacement fixes only the one room that's damaged, leaving the other two intact.

Preserving the healthy parts of the knee may help maintain more natural movement. The ligaments and surrounding tissue stay in place, and the joint may feel more like the original — something patients often describe as the knee "disappearing" when they walk.

Inside the trial

This was a rigorous double-blinded, multicenter randomized trial — the gold standard in medical research. Surgeons at 10 hospitals enrolled 350 patients with arthritis specifically limited to the inner front section of the knee. Patients ranged in age, with an average around 67 years. Neither the patients nor the doctors evaluating their outcomes knew which surgery had been performed. Researchers followed everyone for two years.

What patients actually experienced

The primary measure was the Oxford Knee Score (OKS), a patient-reported rating of knee pain and function. The mUKA group scored an average of 3.5 points higher than the TKA group over two years. That difference was statistically significant — meaning it was unlikely to be random chance.

But there's a catch.

The medical community generally considers 4 to 5 points the minimum difference a patient would notice in daily life. So while the partial replacement group did better on paper, the difference in the main score sat just below that meaningful threshold.

Where the gap really showed up

That's not the full story, though. On four other measures, the gap was large enough to matter in real life.

The "Forgotten Joint Score" — a measure of how often patients are reminded by their knee that it exists — favored mUKA by 14 points, a clearly meaningful difference. Patients in the mUKA group also bent their knee further, reported fewer knee symptoms, and felt less bodily pain. These are the things people care about when they're trying to climb stairs or take a walk.

There was also a practical safety advantage. About 7% of TKA patients needed a follow-up procedure under anesthesia to loosen a stiff knee. Only about 2% of mUKA patients needed that.

Both surgeries produced good outcomes overall — the question is which one produces better ones for your specific situation.

Putting this in context

This is one of the largest and most rigorous trials to directly compare these two operations. The findings add important weight to the idea that for patients whose arthritis is confined to one part of the knee, a partial replacement may offer a more natural recovery. This aligns with a broader trend in surgery toward doing less when less is appropriate.

If you have knee arthritis and are considering surgery, ask your orthopedic surgeon whether your damage is limited to one compartment of the joint. Not everyone qualifies for a partial replacement — it requires a specific pattern of arthritis, good ligament function, and an experienced surgical team. But if you do qualify, this evidence suggests it is worth a serious conversation.

This trial followed patients for only two years. Knee replacement is designed to last decades, so longer follow-up is needed. The study also required specific entry criteria, meaning the results apply only to patients with isolated anteromedial arthritis — not all knee OA patients.

Researchers plan longer follow-up of the same patient group to see whether the early advantages of partial replacement hold at five and ten years, or whether revision rates eventually equalize. Those results will be critical for refining surgical guidelines and helping patients and surgeons make better long-term decisions together.

Study Details

Study typeRct
Sample sizen = 350
EvidenceLevel 2
Follow-up24.0 mo
PublishedApr 2026
View Original Abstract ↓
BACKGROUND: The superiority of medial unicompartmental knee arthroplasty (mUKA) versus total knee arthroplasty (TKA) for isolated anteromedial knee osteoarthritis (AMOA) remains a subject of ongoing debate. We present the 2-year results of a multicenter, randomized trial comparing the patient-reported and clinical outcomes of these 2 implant types in the treatment of AMOA. METHODS: This double-blinded superiority trial recruited patients with severe AMOA at 10 arthroplasty centers and randomized them to undergo either mUKA or TKA. The primary outcome was the average improvement in the Oxford Knee Score (OKS) over 2 years, analyzed by intention-to-treat. A range of patient-reported outcomes served as secondary outcomes. Death, revision, and other reoperations were analyzed as serious adverse events (SAEs). RESULTS: Between September 2017 and March 2021, 350 patients were randomized: 177 (79 female, 98 male; mean age, 67.7 ± 7.5 years) to mUKA and 173 (84 female, 89 male; mean age, 66.7 ± 7.8 years) to TKA. The average 2-year OKS improvement differed by 3.5 points (95% CI, 2.3 to 4.7; p < 0.001) in favor of mUKA, although this difference was below the generally accepted minimal clinically important difference (MCID) of 4 to 5 points. Ten of the 12 secondary outcomes favored mUKA, while the remaining 2 were nonsignificant. The differences in the Forgotten Joint Score (FJS) (14.1; 95% CI, 9.5 to 18.6), range of motion during the first 2 years (7.0°; 95% CI, 5.3° to 8.7°) and at 2 years (5.5°; 95% CI, 3.6° to 7.4°), Knee injury and Osteoarthritis Outcome Score (KOOS) symptoms score (10.3; 95% CI, 7.8 to 12.8), and Short Form-36 (SF-36) bodily pain score (7.6; 95% CI, 4.1 to 11.1) all favored mUKA and reached the MCID. Non-revision reoperations were performed in 4 patients (2.3%) after mUKA and in 12 patients (6.9%) after TKA (9 of the 12 underwent manipulation under anesthesia); the difference was 4.7% (95% CI, 0.2% to 9.8%). There were no differences in the rates of revision or death between the groups. CONCLUSIONS: Averaged over the 2-year follow-up, mUKA demonstrated minor advantages that did not achieve clear clinical superiority on the basis of the OKS difference. However, the FJS, range of motion, KOOS symptoms score, and SF-36 bodily pain score all demonstrated differences in favor of mUKA that were clinically meaningful. The overall findings suggest that mUKA and TKA yield similarly favorable short-term results, with small advantages for mUKA. LEVEL OF EVIDENCE: Therapeutic Level I . See Instructions for Authors for a complete description of levels of evidence.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.